Results 141 to 150 of about 22,737 (222)

Toll like receptor 4 (TLR4) in neuroinflammation: From acute hemorrhagic stroke to chronic neurodegeneration. [PDF]

J Cereb Blood Flow Metab
Choudhary HH, Yoshida J, Islam R, Wang Z, Hanafy KA.   +4 more
europepmc   +1 more source

TRIM56 Promotes Antiviral Responses Downstream of TLR4. [PDF]

Viruses
Tong X, Li NL, Yang D, Liu BM, Li ZA, Li K.   +5 more
europepmc   +1 more source

Japanese encephalitis virus NS1 and NS4B synergistically target TLR3 signaling to promote viral replication. [PDF]

mBio
Zeng Q, He M, Li M, Yang D, Wang L, Hao C, Wang Z, Zhou M, Zhu T, Niu X, Chen Z, Zhang B, Zu S, Ding X, Wei Z, Chu H, Zhang H.   +16 more
europepmc   +1 more source

Hyperbaric oxygen treatment and toll-like receptor 5 in radioprotection of epithelial cells. [PDF]

PLoS One
Sallam L, Rychlíková L, Mölne J, Bergo MO, Naluai ÅT, Seeman-Lodding H, Oscarsson N, Giglio D.   +7 more
europepmc   +1 more source

Toll-like Receptor 3 as a Context-Dependent Molecular Switch in Epithelial Cancers: Balancing Cell Death and Tumor-Supportive Programs. [PDF]

Int J Mol Sci
Pérez-Baños A, Tittarelli A.
europepmc   +1 more source

A developmentally informed narrative review of Toll-like receptors in adult and pediatric acute respiratory distress syndrome. [PDF]

Ann Transl Med
Foo CWT, Tan HL, Leong JY, Yeo JG, Albani S, Wong JJM.   +5 more
europepmc   +1 more source

The central function and specific molecular mechanisms of the TLR4 pathway underlying impaired intestinal barrier in necrotizing enterocolitis. [PDF]

Biochem Biophys Rep
Ren X, Su X, Arigong G.
europepmc   +1 more source

Dehydroandrographolide attenuates Toll-like receptor signaling by dual inhibition of MyD88- and TRIF-dependent pathways. [PDF]

Sci Rep
Lee YE, Ko H, Lee D, Park HE, Kim SY, Park G, Kim S, Lee Y, Youn HS, Gu GJ.   +9 more
europepmc   +1 more source

Toll-like receptor signaling outcome is determined by the stoichiometry of the endogenous TRIFosome. [PDF]

Sci Adv
Moncrieffe MC, Suresh P, Boyle J, Cui Y, Nawalpuri B, Verstak B, Zhang YP, Zhang Z, Taylor M, Egelman EH, Gay N, Klenerman D, Bryant C.   +12 more
europepmc   +1 more source

Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions. [PDF]

Front Immunol
Zhou J, Liu B, Yang Q, Zhou J, Zheng J, Chen Y, Fu L, Du J, Zhang Z, Zhang J, Li C.   +10 more
europepmc   +1 more source